Dermatology

The AJMC® Dermatology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the skin, hair, and nails.

Latest News

Alopecia areata. | Image Credit: cattyphoto - stock.adobe.com
Study Highlights Unmet Needs in Measuring Patient Experiences in Alopecia Areata

April 29th 2025

Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported outcome measures (PROMs) specific to alopecia areata (AA), a common hair loss condition with substantial quality of life impacts.

Chronic hand eczema. | Image Credit: IIIRusya - stock.adobe.com
Chronic Hand Eczema Has Significant Impacts on Patients' Lives, Survey Reveals

April 22nd 2025

Raj Chovatiya, MD, PhD, MSCI
Addressing Unmet Needs, Emerging Treatment for Atopic Dermatitis: Raj Chovatiya, MD, PhD

April 9th 2025

Migrant Populations. | Image Credit: wladimir1804 - stock.adobe.com
Review Explores Skin Health Risks of US Migrant Populations

April 9th 2025

Research presented. | Image Credit: somneuk - stock.adobe.com
Managing Skin Conditions: Highlighting Ruxolitinib Cream, Phototherapy Efficacy and Cost

April 8th 2025

Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access

Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.

Atopic Dermatitis Payer Perspectives
Continuing Medical Education
View All
May 1st 2025

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology
May 1st 2025

Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care

1.5 Credits / Dermatology

More News

dr steve feldman
July 30th 2024

Dr Steve Feldman: New Atopic Dermatitis Treatments Effective in Managing Inflammation, Alleviating Itch

Brooke McCormick
Steve Feldman, MD, PhD, of Wake Forest University School of Medicine, discusses various effective treatments for alleviating itch in patients with atopic dermatitis (AD), including dupilumab and Janus kinase (JAK) inhibitors.
Trichologist examines child scalp. | Image Credit: Nadzeya - stock.adobe.com
July 24th 2024

Exploring Comorbidities, Dupilumab Treatment in Pediatric Alopecia Areata

Cameron Santoro
Two posters presented at the Society for Pediatric Dermatology Annual Meeting explored common health conditions linked to childhood alopecia areata and the effectiveness of dupilumab treatment in children with both alopecia areata and atopic dermatitis.
Man with atopic dermatitis on his hands | Image Credit: Ольга Тернавская
July 19th 2024

Long-Term Oral Corticosteroid Use Linked to Adverse Event Risk in Atopic Dermatitis

Brooke McCormick
Patients with atopic dermatitis who use oral corticosteroids for more than 90 days have a slightly increased risk of adverse events like myocardial infarction and hyperlipidemia.
Girl scratching itch | Image credit: kwanchaichaiudom - stock.adobe.com
July 18th 2024

SPD Annual Meeting Covered All Facets of Pediatric Dermatology

Julia Bonavitacola
The Society for Pediatric Dermatology (SPD) Annual Meeting focused on different aspects of pediatric dermatology, including topical treatments, technology, and misinformation.
Science article writing composition. | Image Credit: Macrovector - stock.adobe.com
July 18th 2024

New Study Suggests Alopecia After COVID-19 Vaccine Rare but Possible

Cameron Santoro
A literature review found a link between COVID-19 vaccination and alopecia, with most cases experiencing hair loss within 1 month after the first dose. However, the small sample size and limited data call for further investigation.
timothy caulfield, JD
July 16th 2024

Timothy Caulfield on Enhancing Information Dissemination in Pediatric Dermatology

Skylar Jeremias Brooke McCormick
Timothy Caulfield, JD, research director of the Health Law Institute at the University of Alberta, discusses strategies for building trust, overcoming cultural and language barriers, and enhancing interdisciplinary collaboration in pediatric dermatology at the Society of Pediatric Dermatology conference.
Dosage and immunosuppression should be taken into account when biologics are used for children with different skin conditions | Image credit: Марина Терехова - stock.adobe.com
July 15th 2024

Using Biologic Therapies Safely in Pediatric Patients With Skin Conditions

Julia Bonavitacola
Experts in dermatology presented ways in which biologic therapies can be given and the duration of treatment when used in pediatric patients with skin conditions.
Hidradenitis suppurativa | Image credit: Lea - stock.adobe.com
July 15th 2024

Hidradenitis Suppurativa Causes Psychosocial Impact in Children

Julia Bonavitacola
Posters presented at the Society for Pediatric Dermatology Annual Meeting found that pediatric deroofing can lead to patient satisfaction later in life.
Topical therapy | Image credit: Victor Moussa - stock.adobe.com
July 14th 2024

Ways to Use Nonsteroidal Topical Therapies in the Treatment of Skin Conditions

Julia Bonavitacola
Updates in nonsteroidal topical therapies were presented during a session at the Society for Pediatric Dermatology Annual Meeting.
ChatGPT | Image credit: Timon - stock.adobe.com
July 13th 2024

Can ChatGPT Replace Doctors? Generative AIs Provide New Tool in Dermatology

Julia Bonavitacola
A presentation at the Society for Pediatric Dermatology Annual Conference discussed how to use generative artificial intelligence (AI) to improve processes while working in the dermatology space.
Debate | Image credit: Right 3 - stock.adobe.com
July 12th 2024

Friendly Debates Spark Discussion on Infantile Hemangioma, Vitiligo, and Atopic Dermatitis

Julia Bonavitacola
The Society for Pediatric Dermatology (SPD) Annual Meeting featured a new debates segment where experts in the field discussed preferred strategies for the treatment of pediatric skin conditions.
Child with vitiligo | Image credit: ChayTee - stock.adobe.com
July 12th 2024

Ruxolitinib Cream Dose Safe, Effective in Children With Atopic Dermatitis, Vitiligo

Julia Bonavitacola
Twice-daily application of 1.5% ruxolitinib cream was found to be effective in children and adolescents with atopic dermatitis and vitiligo.
FDA approval | Image Credit: Olivier Le Moal - stock.adobe.com
July 9th 2024

FDA Approves Roflumilast for Patients 6 Years and Older With Atopic Dermatitis

Brooke McCormick
Today, the FDA approved roflumilast cream 0.15% (Zorvye; Arcutis Biotherapeutics) for the treatment of mild to moderate atopic dermatitis in patients 6 years and older.
Female patient with vitiligo | Image Credit: shurkin_son - stock.adobe.com
July 9th 2024

Study Finds Patients With Vitiligo at Higher Risk for Rheumatoid Arthritis, Systemic Lupus Erythematosus

Brooke McCormick
Patients with vitiligo have a higher genetic risk of developing rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
Child rash | Image credit: Piman Khrutmuang - stock.adobe.com
July 8th 2024

Society for Pediatric Dermatology Annual Meeting Sets Focus on Topical Treatments, Technology

Julia Bonavitacola
The annual meeting will take place in Toronto July 11-15, 2024.
Iltefat Hamzavi, MD, an expert on hidradenitis suppurativa
July 1st 2024

Comorbidities and Coordinating Care Between Specialists in Hidradenitis Suppurativa

Iltefat Hamzavi, MD
Iltefat Hamzavi, MD, outlines comorbidities associated with hidradenitis suppurativa and discusses best practices for coordinating care between specialists.
Iltefat Hamzavi, MD, an expert on hidradenitis suppurativa
July 1st 2024

Overview of the Hurley Staging System for Hidradenitis Suppurativa

Iltefat Hamzavi, MD
An expert on hidradenitis suppurativa describes the characteristics for each of the 3 stages in the Hurley staging system and how they inform treatment decisions.
Young black woman with hair concern| Image Credit: Prostock-studio-stock.adobe.com
July 1st 2024

Survey Shows Suboptimal Comfort in Treating Hair Among Patients With SOC

AJMC Contributor
In addition to ensuring residency programs provide educational and practical opportunities for addressing skin of color (SOC) hair-related concerns, prioritizing having residents of diverse backgrounds can help close knowledge and comfort gaps, suggest researchers.
patient with vitiligo covering her face with her hands | Image Credit: Savory - stock.adobe.com
June 28th 2024

Study Finds Israeli Patients With Vitiligo at Lower Risk for Parkinson Disease

Brooke McCormick
Israeli patients with vitiligo exhibit a significantly reduced risk of developing Parkinson disease (PD).
A dermatologist wearing gloves examines the skin of a sick patient. Examination and diagnosis of skin diseases-allergies, psoriasis, eczema, dermatitis | Image credit: © fusssergei - stock.adobe.com
June 26th 2024

Researchers Explore Deeper Connection Between AD, Food Allergy

AJMC Contributor
With an emerging hypothesis that inflammation of the skin prompts intestinal remodeling through various mechanisms, researchers explored the role of inflammatory signals, microbiome alterations, metabolites, and the nervous system.
Iltefat Hamzavi, MD, an expert on hidradenitis suppurativa
June 24th 2024

Differential Diagnosis When Considering Hidradenitis Suppurativa in a Patient

Iltefat Hamzavi, MD
A dermatologist provides clinical insights on differential diagnosis strategies when considering hidradenitis suppurativa in patients and the challenges associated with diagnosis.
Iltefat Hamzavi, MD, an expert on hidradenitis suppurativa
June 24th 2024

The Pathophysiology of Hidradenitis Suppurativa

Iltefat Hamzavi, MD
Iltefat Hamzavi, MD, describes the pathophysiology of hidradenitis suppurativa and associated comorbidities that are commonly seen in patients.
Psoriasis. Acute psoriasis on the knees, body, elbows is an autoimmune, incurable dermatological skin disease | nuzza11 - stock.adobe.com
Published: June 21st 2024 | Updated: June 21st 2024

Autoimmune Diseases Prevalent Among Patients With Psoriasis, Study Finds

Pearl Steinzor
Researchers have identified a link between psoriasis and the autoimmune diseases hypothyroidism and alopecia areata.
Pregnant woman holding stomach | Image Credit: pressmaster - stock.adobe.com
June 20th 2024

Study: Atopic Dermatitis Severely Impacts Female Patients' Sexuality, Quality of Life

Brooke McCormick
Atopic dermatitis significantly impairs female patients' sexual function, reproductive desires, and overall quality of life.
Iltefat Hamzavi, MD, an expert on hidradenitis suppurativa
June 17th 2024

Epidemiology and Impact of Hidradenitis Suppurativa

Iltefat Hamzavi, MD
An expert on hidradenitis suppurativa discusses the epidemiology of the disease and its profound impact on patients’ lives.
Iltefat Hamzavi, MD, an expert on hidradenitis suppurativa
June 17th 2024

Signs and Symptoms of Hidradenitis Suppurativa (HS)

Iltefat Hamzavi, MD
Iltefat Hamzavi, MD, introduces a discussion on the treatment of hidradenitis suppurativa with an overview of the signs and symptoms of the disease.
Salt shaker spilled on table | Image Credit: Sebastian Studio - stock.adobe.com
June 11th 2024

Study Links Dietary Sodium Intake to Increased Atopic Dermatitis Prevalence, Severity

Brooke McCormick
Excessive dietary sodium intake is linked to increased prevalence and severity of atopic dermatitis (AD).
Center on Health Equity and Access
June 8th 2024

Health Equity and Access Weekly Roundup: June 8, 2024

Giuliana Grossi
This week, the Center on Health Equity and Access covered the release of the best US hospitals for equitable access, news from the CMS Health Equity conference, biomarker testing legislation, and insights on improving access for queer communities and the disparities in dermatology.
dr thomas hall
June 5th 2024

Dr Thomas Hall Explores How Geographic, Socioeconomic Factors Affect Dermatological Outcomes

Pearl Steinzor Brooke McCormick
Thomas Hall, MD, FAAD, of US Dermatology Partners, explains that disparities in dermatological care arise from the uneven distribution of dermatologists, especially in rural areas, causing delayed diagnoses and higher health care costs.
Shawn Kwatra, MD
May 30th 2024

Dr Shawn Kwatra Discusses Study Results for Nemolizumab in Prurigo Nodularis

Skylar Jeremias Pearl Steinzor
Shawn Kwatra, MD, dermatologist, John Hopkins University, recounts his study assessing the use of nemolizumab in prurigo nodularis presented at the American Academy of Dermatology conference.
<12345678
...
10>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo